Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.

Wang X, Xue Q, Wu L, Wang B, Liang H

DOI: 10.1002/2211-5463.12404
Published: 2018 May
Container: FEBS open bio
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/2211-5463.12404,
  title = {Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.},
  author = {Wang X and Xue Q and Wu L and Wang B and Liang H},
  year = {2018},
  journal = {FEBS open bio},
  doi = {10.1002/2211-5463.12404},
  url = {https://doi.org/10.1002/2211-5463.12404}
}

RIS

TY  - JOUR
TI  - Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.
AU  - Wang X
AU  - Xue Q
AU  - Wu L
AU  - Wang B
AU  - Liang H
PY  - 2018
JO  - FEBS open bio
DO  - 10.1002/2211-5463.12404
UR  - https://doi.org/10.1002/2211-5463.12404
ER  -

APA

X, W., Q, X., L, W., B, W., & H, L. (2018). Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.. FEBS open bio. https://doi.org/10.1002/2211-5463.12404

Source records

pubmed · retrieved 2026-09-24T19:52:53.329Z
europe-pmc · retrieved 2026-09-24T19:52:53.355Z
doaj · retrieved 2026-09-24T19:52:53.344Z